Menu

E-Education

E-Education

Watch recordings from our past Educational Events at your leisure anywhere and anytime! Our E-Education has more than 400 presentations that cover important Alpha-1 related topics.

You can also search for more presentations on Vimeo at http://vimeo.com/a1f

This program provides the Alpha-1 Community with access to educational programs from our National Conference and National Education Series.

We gratefully acknowledge all our speakers who volunteered their time and gave permission to record and disseminate their presentations.

Divider
  
Respiratory Infection and Alpha-1

Christopher Czaja , MD's, Bio:plus

Christopher A. Czaja, M.D., MPH completed medical school and internal medicine residencyat the University of Pennsylvania. He completed an infectious diseases fellowship at theUniversity of Washington, where he also received his public health degree. In 2007, he joinedthe Division of Mycobacterial and Respiratory Infections at National Jewish Health, and is anAssistant Professor of Medicine at National Jewish Health and at the University of Colorado School of Medicine.

Myths and Realities of Alpha-1

Robert A. Sandhaus, MD's, Bio:plus

Robert “Sandy” Sandhaus graduated from Haverford College in Pennsylvania with a degree in molecular biology. He then received a PhD in cell biology and an MD from the State University of New York at Stony Brook. He completed his residency in internal medicine at the Beth Israel Hospital in Boston and a pulmonary fellowship at the University of California San Francisco (UCSF). He was then appointed to the UCSF medical faculty and subsequently joined the medical faulty at the University of Colorado School of Medicine in 1981 where he founded the Alpha1-Antitrypsin Deficiency Program at National Jewish Medical and Research Center in Denver and remains its director. His research throughout his academic career has centered on the role of white blood cell enzymes in the prevention and promotion of lung disease. This work led to a special clinical interest in patients with the genetic deficiency of alpha-1 antitrypsin. In addition to his ongoing academic career. Dr. Sandhaus briefly left medical practice to work in research and development in the biopharmaceutical industry. He ran clinical development programs at Cortech, NeXstar Pharmaceuticals, and Gilead Sciences. Dr. Sandhaus has served on the Boards of Directors of the Alpha-1 Association, the Alpha-1 Foundation, AlphaNet, and the Osteogenesis Imperfecta Foundation. For the past five years, he has been the Executive Vice President and Medical Director of AlphaNet and the Clinical Director of the Alpha-1 Foundation. He is board certified in internal medicine, pulmonary disease, and critical care medicine. He lives in Bow Mar, Colorado.

Overview of Alpha-1 Antitrypsin Deficiency

Michael Krowka, MD's, Bio:plus

Michael Krowka, MD is a Professor of Medicine, and the Vice Chair of the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic in Rochester, MN, a position he has held since 2001. He also chairs the Mayo Clinic Public Affairs Committee. His chief interest lies in the study of Pulmonary hypertension associated with liver diseases. When asked why he chose to serve on the Alpha-1 Association Board, Dr. Krowka responded, "I have enjoyed my volunteer roles with the Alpha-1 community and physicians since the late 1980's. Most recently, I have served on and chaired the Education Materials Working Group (EMWG) for the Alpha -1 Foundation. As Vice-Chair of the Pulmonary Division at the Mayo Clinic (with clinical interests in pulmonary hypertension, lung volume reduction and lung transplantation), my clinical research derives from daily pulmonary consultation in the Mayo Liver Transplant Clinic, which allows me to see patients with Alpha-1 issues from the liver transplantation perspective. Thus, the ongoing education of pulmonary and hepatology Fellows/Residents regarding alpha-1 antitrypsin deficiency is a continued high priority and daily activity. Finally, I see the educational and research relationships between various lung and liver patient care and professional organizations as an important integration to be fostered via training our young physicians to explore innovative approaches to Alpha-1 patient care. In short, I hope to bring an additional educational emphasis to the Alpha-1 Association Board and contribute ideas that affect both the lung and liver aspects of alpha-1 antitrypsin patient care.

Stem Cells and Gene Therapy for Alpha-1
Topics : Research

Darrell N. Kotton, MD's, Bio:plus

Darrel Kotton is the Co-Director of the Center for Regenerative Medicine at Boston University, and an Associate Professor in the Department of Medicine and in the Department of Pathology and Laboratory Medicine at Boston University School of Medicine. His research focuses on stem cell biology and gene therapy related to lung injury and repair. He specializes in the genetic manipulation of stem cells as well as resident lung cells Projects in his lab currently focus on utilizing novel vectors for the study of alpha-1 antitrypsin deficiency, COPD, Cystic Fibrosis, and lung inflammatory pathways.


Search


Search


Search

Sponsors

Thank you to our generous program sponsors.

Alphanet
 
CSL Behring
 
EVERSANA
 
Grifols